NCT02771405 2026-04-13
FRI-STC
National Hepatology & Tropical Medicine Research Institute
Phase 3 Completed
Clinical Trials
24 trialsNCT01309490 2025-07-29
Phase I/II Study of Ribavirin Given as Monotherapy in Solid Tumour Cancer Patients
Jewish General Hospital
Phase 1/2 Terminated
NCT02940496 2025-07-15
Pembrolizumab (MK-3475) in Hepatocellular Carcinoma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT05717400 2024-12-31
Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy
M.D. Anderson Cancer Center
Phase 4 Terminated
NCT01056523 2023-10-02
Use of Ribavirin and Low Dose Ara-C to Treat Acute Myeloid Leukemia
Jewish General Hospital
Phase 1/2 Completed
NCT01268579 2023-10-02
Pharmacodynamic Effects of Ribavirin in Patients With Tonsil and/or Base of Tongue Squamous Cell Carcinoma
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT02073838 2023-09-29
Ribavirin and Hedgehog Inhibitor With or Without Decitabine in AML
Jewish General Hospital
Phase 2 Completed
NCT02308241 2023-01-05
Ribavirin for Patients With Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT00559091 2022-12-22
Borden-001
Jewish General Hospital
Phase 2 Completed
NCT03760666 2022-08-08
A Study of Brequinar in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
Clear Creek Bio, Inc.
Phase 1/2 Terminated
NCT03585725 2021-09-27
A Pilot Investigator-Initiated Study of Ribavirin in Indolent Follicular Lymphoma and Mantle Cell Lymphoma
Weill Medical College of Cornell University
Phase EARLY_PHASE1 Terminated
NCT01502072 2021-02-15
Respiratory Syncytial Virus - RSV Protocol
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01821963 2020-09-24
Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT02717949 2019-01-08
Optimal
University of Texas Southwestern Medical Center
Phase 4 Terminated
NCT02328651 2018-08-07
Effect of Xiaoer Jiebiao Oral Liquid on Hand-foot-mouth Disease
Children's Hospital of Fudan University
Phase 4 Completed
NCT01721525 2017-10-25
Induction Chemotherapy With Afatinib, Ribavirin, and Weekly Carboplatin/Paclitaxel for Stage IVA/IVB HPV Associated Oropharynx Squamous Cell Cancer (OPSCC)
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT02959359 2017-08-07
DAA in the Risk of Recurrence After Curative Treatment of HCC
Taipei Veterans General Hospital, Taiwan
Phase 4 Withdrawn
NCT01559844 2016-07-27
Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant
Gilead Sciences
Phase 2 Completed
NCT00897312 2016-04-25
Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease
Vanderbilt-Ingram Cancer Center
Terminated
NCT01056757 2015-11-04
Treatment With Ribavirin for Patients With Metastatic Breast Cancer
Jewish General Hospital
Phase 1/2 Terminated
NCT00375661 2015-09-02
Low-dose Peg-interferon Plus Ribavirin (IFN/RBV) for Prevention of Hepatocellular Carcinoma (HCC) Recurrence in Patients Who Had Surgery to Remove Primary HCC
Kyoto University Hospital
Phase 4 Completed
NCT00500578 2012-08-01
Intermittent Use of Aerosolized Ribavirin for Treatment of RSV
M.D. Anderson Cancer Center
Phase 4 Completed
NCT00014391 2010-04-02
Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation
Fred Hutchinson Cancer Center
Phase 3 Completed
NCT00834860 2010-02-15
Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular Carcinoma
Kaohsiung Medical University Chung-Ho Memorial Hospital
Phase 4 Unknown